miR-16 controls myoblast proliferation and apoptosis through directly suppressing Bcl2 and FOXO1 activities

Xinzheng Jia1, Hongjia Ouyang1, Bahareldin Ali Abdalla1

  • 1Department of Animal Genetics, Breeding and Reproduction, College of Animal Science, South China Agricultural University, Guangzhou, Guangdong 510642, China; Guangdong Provincial Key Lab of Agro-Animal Genomics and Molecular Breeding, and Key Lab of Chicken Genetics, Breeding and Reproduction, Ministry of Agriculture, Guangzhou, Guangdong 510642, China.

Insights

MicroRNA-16 (miR-16) suppresses avian myogenesis by inhibiting myoblast proliferation and promoting apoptosis. It targets Bcl2 and FOXO1, impacting muscle growth and mass.

Area of Science:

  • Molecular Biology
  • Developmental Biology
  • Muscle Biology

Background:

  • Myogenesis is a complex process involving myoblast proliferation, differentiation, apoptosis, and fusion.
  • While muscle-specific regulators are known, few microRNAs (miRNAs) have been identified to coordinate these events.
  • Understanding miRNA-mediated regulation is crucial for muscle development and mass maintenance.

Purpose of the Study:

  • To investigate the role of miR-16 in avian myogenesis.
  • To identify the direct molecular targets of miR-16 involved in muscle development.
  • To elucidate the mechanism by which miR-16 regulates myoblast proliferation and apoptosis.

Main Methods:

  • Quantitative analysis of miR-16 expression in chicken pectoral muscle.
  • In vitro experiments to assess the effects of miR-16 on myoblast proliferation and apoptosis.
  • Bioinformatic and biochemical analyses to identify direct targets of miR-16 (Bcl2 and FOXO1).
  • Functional studies involving inhibition of Bcl2 and FOXO1.
  • Chromatin immunoprecipitation coupled with high-throughput sequencing (ChIP-seq) to analyze FOXO1-bound genes.

Main Results:

  • miR-16 expression was significantly decreased in hypertrophic pectoral muscle.
  • Overexpression of miR-16 inhibited myoblast proliferation and promoted apoptosis in vitro.
  • Bcl2 and FOXO1 were confirmed as direct targets of miR-16.
  • Inhibition of Bcl2 or FOXO1 mimicked the effects of miR-16 on myogenesis.
  • FOXO1 was identified as a core target mediating growth-related pathways (PI3K-AKT-MAPK, PI3K-AKT-mTOR).
  • ChIP-seq identified 234 FOXO1-bound genes enriched in myogenic proliferation, death, and hypotrophy pathways.

Conclusions:

  • miR-16 acts as a key regulator suppressing avian myogenesis.
  • It controls myoblast proliferation and apoptosis by targeting Bcl2 and FOXO1.
  • FOXO1 plays a central role in mediating miR-16's effects on myogenic pathways.
  • This study reveals a novel mechanism for miR-16 in maintaining skeletal muscle mass.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.2K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.4K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
9.0K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
5.7K